Clinical Trials

Clinical Trial Detail

Return to search results.

A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer (XCITE)

Complete title: A Phase III Double-blinded, Placebo Controlled Study of XilonixTM for Improving Survival in Metastatic Colorectal Cancer

Research Study Number       8041
Principal Investigator       Andrew Coveler, MD
Phase       III

Look up trial at NIH

Research Study Description

The purpose of this study is to determine if the True Human Monoclonal antibody Xilonix (MABp1) can prolong the life of colorectal carcinoma patients that are refractory to standard therapy.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number       8041
Contact       Seattle Cancer Care Alliance Intake Office
Telephone       800-804-8824 / 206-288-1024

Colon Cancer; Gastrointestinal Cancer; Solid Tumors; Digestive System Neoplasms; Colorectal Neoplasms

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials